Metronidazole News

Nitazoxanide Appears Effective Against Clostridium Difficile Disease: Presented at DDW

A pilot study shows that nitazoxanide might work to treat Clostridium difficile, which means that it could become an alternative to vancomycin -- the only drug that has US Food and Drug Administration labelling for treatment of...

Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria

Targanta Therapeutics Corporation today released data from two studies comparing the in vitro activity of its lead antibiotic drug candidate, oritavancin, to that of other antibiotics against Clostridium difficile bacteria....

Final Report of Ushercell as Treatment for Bacterial Vaginosis Released

Polydex Pharmaceuticals Limited (Nasdaq:POLXF) announces that a final report has been received from Dr. Jose Simoes, the Principal Investigator in a Phase II human clinical trial of Ushercell to study the potential treatment and...

Bacteria Genome Shows Mobile Genes Help Develop Resistance

The bacterium Clostridium difficile has a "pick and mix" approach to its genes, analysis of its genome sequence has shown.

How hospital bug can evade attack

Scientists have decoded the genetic make-up of a bacterium responsible for many hospital-acquired infections - and shown why it is so difficult to tackle.

Displaying results 1 to 5 out of 7

1

2

Next >

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.